Then why did MSB say they would provide the evidence requested by the FDA by doing another clinical trial, as I posted above.
We don't know exactly what the FDA said, but we can see what MSB officially said in response.
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-345
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
0.005(0.38%) |
Mkt cap ! $1.507B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.31 | $449.4K | 339.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 13823 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 26707 | 13 |
View Market Depth
| Last trade - 11.04am 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |